Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/3/26 19:48 | 4/2/26 | IMNM | Health | Drug | Pharmaceutical Preparations | Higgins Jack | WA | O | Chief Sc | 1 | S | -204 | 21.64 | 0 | -9 | 25 | D | |||||||||||||||
4/3/26 19:46 | 4/2/26 | IMNM | Health | Drug | Pharmaceutical Preparations | Rosett Max | WA | O | CFO | 2 | M.d | 1,512 | 11.07 | 0 | 137 | 54 | D | |||||||||||||||
4/3/26 19:46 | 4/2/26 | IMNM | Health | Drug | Pharmaceutical Preparations | Rosett Max | WA | O | CFO | 2 | S.d | -1,512 | 11.07 | 0 | -137 | 54 | D | |||||||||||||||
3/31/26 07:11 | 3/27/26 | IMNM | Health | Drug | Pharmaceutical Preparations | Siegall Clay B | WA | DO | P,CEO | 1 | P | 501 | 19.67 | 0 | 25 | 4 | 691 | D | ||||||||||||||
3/23/26 21:23 | 3/20/26 | IMNM | Health | Drug | Pharmaceutical Preparations | Wagenheim Philip | WA | D | 1 | S.m | -1,336 | 20.55 | 0 | -65 | 341 | D | ||||||||||||||||
3/12/26 06:05 | 3/10/26 | IMNM | Health | Drug | Pharmaceutical Preparations | Bienaime Jean Jacques | WA | D | 1 | P.m | 44 | 21.84 | 0 | 2 | 5 | 38 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |